Literature DB >> 1593323

Osseous regeneration in the presence of four common hemostatic agents.

M D Finn1, S R Schow, E D Schneiderman.   

Abstract

The iliac crest is a common site for bone procurement in oral and maxillofacial surgery. The goal of this study was to evaluate the potential for bone regeneration in the presence of four common hemostatic agents in a manner that parallels iliac bone procurement in humans. The agents evaluated were 1) Avitene (microfibrillar collagen; Medchem Products, Inc, Woburn, MA); 2) bone wax (beeswax with isopropyl palmitate; Ethicon, Inc, Somerville, NJ); 3) Gelfoam (absorbable gelatin sponge; The Upjohn Company, Kalamazoo, MI); and 4) Surgicel (oxidized regenerated cellulose; Johnson & Johnson Products, Inc, Patient Care Division, New Brunswick, NJ). Five surgical defects in each of four dogs were created for placement of the four materials; one defect served as an empty control site. The dogs were then allowed to heal over a 2-month period. Radiographic and histologic examination showed new bone formation in the presence of Avitene, Surgicel, and Gelfoam. Residual material incorporated in bone, without foreign-body response, was noted in the Avitene and Gelfoam sites. Bone wax, however, showed an intense foreign-body reaction, characterized by giant cells, plasma cells, fibrous granulation tissue, and lack of bone reformation. On the basis of these initial findings, it was concluded that Surgicel, Avitene, and Gelfoam may be adequate hemostatic agents for use in iliac bone procurement, whereas the use of bone wax appears to be contraindicated.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1593323     DOI: 10.1016/0278-2391(92)90443-4

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  22 in total

Review 1.  The use of local agents: bone wax, gelatin, collagen, oxidized cellulose.

Authors:  Claudio Schonauer; Enrico Tessitore; Giuseppe Barbagallo; Vincenzo Albanese; Aldo Moraci
Journal:  Eur Spine J       Date:  2004-06-22       Impact factor: 3.134

2.  Osseous regeneration in the presence of oxidized cellulose and collagen.

Authors:  G J Dias; P V Peplow; F Teixeira
Journal:  J Mater Sci Mater Med       Date:  2003-09       Impact factor: 3.896

3.  The effect of alloplastic bone graft and absorbable gelatin sponge in prevention of periodontal defects on the distal aspect of mandibular second molars, after surgical removal of impacted mandibular third molar: a comparative prospective study.

Authors:  Manju Singh; Kalyani Bhate; Deepak Kulkarni; S N Santhosh Kumar; Rahul Kathariya
Journal:  J Maxillofac Oral Surg       Date:  2013-11-14

4.  In vivo engineering of organs: the bone bioreactor.

Authors:  Molly M Stevens; Robert P Marini; Dirk Schaefer; Joshua Aronson; Robert Langer; V Prasad Shastri
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-29       Impact factor: 11.205

5.  Gelatin sponges (Gelfoam) as a scaffold for osteoblasts.

Authors:  Ramin Rohanizadeh; Michael V Swain; Rebecca S Mason
Journal:  J Mater Sci Mater Med       Date:  2007-08-15       Impact factor: 3.896

Review 6.  Biotechnology and bone graft substitutes.

Authors:  R A Kenley; K Yim; J Abrams; E Ron; T Turek; L J Marden; J O Hollinger
Journal:  Pharm Res       Date:  1993-10       Impact factor: 4.200

7.  Effect of platelet-rich plasma on bone regeneration after removal of cysts and benign tumours of the jaws.

Authors:  Arvind Ramanathan; K M Cariappa
Journal:  Oral Maxillofac Surg       Date:  2013-11-28

8.  Ostene, a new alkylene oxide copolymer bone hemostatic material, does not inhibit bone healing.

Authors:  Clara E Magyar; Tara L Aghaloo; Elisa Atti; Sotirios Tetradis
Journal:  Neurosurgery       Date:  2008-10       Impact factor: 4.654

9.  In vivo assessment of new resorbable PEG-PPG-PEG copolymer/starch bone wax in bone healing and tissue reaction of bone defect in rabbit model.

Authors:  J Suwanprateeb; S Kiertkrittikhoon; J Kintarak; W Suvannapruk; F Thammarakcharoen; P Rukskul
Journal:  J Mater Sci Mater Med       Date:  2014-06-10       Impact factor: 3.896

10.  A randomized, controlled, prospective trial to evaluate the haemostatic effect of Lyostypt versus Surgicel in arterial bypass anastomosis: "COBBANA" trial.

Authors:  Petra Baumann; Hardy Schumacher; Johannes Hüsing; Steffen Luntz; Hanns-Peter Knaebel
Journal:  Trials       Date:  2009-09-29       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.